⋮
0
0
シアトル・ジェネティクスと武田薬品がCD30発現末梢性T細胞リンパ腫のフロントライン治療でアドセトリス(ブレンツキシマブ・ベドチン)を検討する第3相ECHELON-2臨床試験の良好なデータを発表
Showing live article 4069 of 9528 in channel 19680784
Article Details:
Author:
Language: Japanese
Channel Number: 19680784
Article Number: 4069
Date: December 10, 2018, 3:28 am
URL: http://www.qlifepro.com/press/20181211-05-38090/ma-takedaseattle-gen-6/
GUID: http://www.qlifepro.com/press/?p=38090
←
$
..going to article 4069
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
No ratings yet.
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL